Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,182,838

« Back to Dashboard

Which drugs does patent 8,182,838 protect, and when does it expire?

Patent 8,182,838 protects SEEBRI and UTIBRON and is included in two NDAs.

This patent has fifty-seven patent family members in twenty-two countries.

Summary for Patent: 8,182,838

Title:	Dry powder composition comprising co-jet milled particles for pulmonary inhalation
Abstract:	The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
Inventor(s):	Morton; David (Chippenham, GB), Staniforth; John (Chippenham, GB)
Assignee:	Vectura Limited (Chippenham, GB)
Application Number:	10/571,146
Patent Claim Types: see list of patent claims	Use; Composition; Delivery;

Drugs Protected by US Patent 8,182,838

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Sunovion Pharms Inc	SEEBRI	glycopyrrolate	POWDER;INHALATION	207923-001	Oct 29, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Sunovion Pharms Inc	UTIBRON	glycopyrrolate ; indacaterol maleate	POWDER;INHALATION	207930-001	Oct 29, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 8,182,838

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0321607.4	Sep 15, 2003

PCT Information
PCT Filed	September 15, 2004	PCT Application Number:	PCT/GB2004/003996
PCT Publication Date:	March 24, 2005	PCT Publication Number:	WO2005/025536

International Family Members for US Patent 8,182,838

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	535233	➤ Sign Up
Australia	2004228757	➤ Sign Up
Australia	2004231342	➤ Sign Up
Australia	2004271779	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant

UBS

Covington

Citi

Fish and Richardson

Express Scripts

Chinese Patent Office

Mallinckrodt

US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.